A study on the bioequivalence of lithium and valproate salivary and blood levels in the treatment of bipolar disorder

Andréa Murru; M. Torra; Antonio Callari; Isabella Pacchiarotti; Soledad Romero; Bernardino González de la Presa; Cristina Varo; José Manuel Goikolea; Víctor Pérez; Eduard Vieta; Francesc Colom

doi:10.1016/j.euroneuro.2017.06.003

Back

A study on the bioequivalence of lithium and valproate salivary and blood levels in the treatment of bipolar disorder

Article 2017 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2015

P.2.d.035 Bioequivalence of blood and salivary levels of lithium and valproate: Implications for the clinical management of bipolar disorder

Andréa Murru, Antonio Callari, Cristina Varo, Mercè Torra, Bruno J. Gonzalez, Eduard Vieta, Francesc Colom

Article2008

Efficacy of Adjunctive Aripiprazole to Either Valproate or Lithium in Bipolar Mania Patients Partially Nonresponsive to Valproate/Lithium Monotherapy: A Placebo-Controlled Study

Eduard Vieta, Caroline T'joen, Robert D. McQuade, William H. Carson, Ronald N. Marcus, Raymond Sanchez, Randall Owen, Laurence Nameche

Article2010

Lithium: Still a Cornerstone in the Long-Term Treatment in Bipolar Disorder?

Alessandra Nivoli, Andréa Murru, Eduard Vieta

Article2010

Lithium Treatment Effects on the Neuropsychological Functioning of Patients With Bipolar I Disorder

Carlos López‐Jaramillo, Juan Pablo Lopera-Vásquez, Jorge Ospina‐Duque, Jenny García Valencia, Aurora Gallo, Vladimir Cortez, Carlos Palacio, Carla Torrent, Anabel Martínez‐Arán, Eduard Vieta

Article2022

Point-of-care test for rapid assessment of blood lithium levels in women with bipolar disorder during perinatal period

M.L. Imaz, M. Torra, M. Martin, I. Aliart, Rocio Martín‐Santos, Eduard Vieta, Lluı̈sa Garcia-Esteve